Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α

BACKGROUND: Zinc-α2-glycoprotein 1 (AZGP1) plays important roles in metabolism-related diseases. The underlying molecular mechanisms and therapeutic effects of AZGP1 remain unknown in non-alcoholic fatty liver disease (NAFLD). AIM: To explore the effects and potential mechanism of AZGP1 on NAFLD in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:World J Gastroenterol
Prif Awduron: Liu, Ting, Luo, Xin, Li, Zheng-Hong, Wu, Jun-Cheng, Luo, Sheng-Zheng, Xu, Ming-Yi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Baishideng Publishing Group Inc 2019
Pynciau:
Basic Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767980/
https://ncbi.nlm.nih.gov/pubmed/31576092
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i36.5451
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg